Frazier Life Sciences Management, L.P. Verona Pharma PLC Transaction History
Frazier Life Sciences Management, L.P.
- $2.36 Billion
- Q3 2025
A detailed history of Frazier Life Sciences Management, L.P. transactions in Verona Pharma PLC stock. As of the latest transaction made, Frazier Life Sciences Management, L.P. holds 3,383,950 shares of VRNA stock, worth $362 Million. This represents 15.27% of its overall portfolio holdings.
Number of Shares
3,383,950
Previous 3,383,950
-0.0%
Holding current value
$362 Million
Previous $320 Million
12.79%
% of portfolio
15.27%
Previous 16.88%
Shares
8 transactions
Others Institutions Holding VRNA
# of Institutions
276Shares Held
77.3MCall Options Held
705KPut Options Held
449K-
Pentwater Capital Management LP Naples, FL5.3MShares$567 Million3.55% of portfolio
-
Hbk Investments L P Dallas, TX4.26MShares$456 Million6.29% of portfolio
-
Fil LTD Hamilton, D03.49MShares$373 Million0.32% of portfolio
-
Davidson Kempner Capital Management LP New York, NY3.27MShares$350 Million10.89% of portfolio
-
Glazer Capital, LLC New York, NY3.21MShares$343 Million11.48% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...